The evaluation of a series of chalcones, which are structurally related to the known Hsp90 inhibitor and antileishmanial compound SU086, in various liver cancer and protozoal parasite models led to remarkable and, in parts, unexpected results. This evidence concerns the gene HSP90AA1 and liver cancer.